Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Calidi Biotherapeutics, Inc. Common Stock
(NY:
CLDI
)
1.320
-0.010 (-0.75%)
Streaming Delayed Price
Updated: 11:49 AM EST, Dec 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Calidi Biotherapeutics, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 11, 2024
Via
Benzinga
Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13
June 11, 2024
From
Calidi Biotherapeutics, Inc.
Via
Business Wire
Why Calidi Biotherapeutics is Moving Higher Monday
↗
June 10, 2024
Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 10, 2024
Via
Benzinga
Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors
June 10, 2024
From
Calidi Biotherapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 05, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
June 05, 2024
Pre-market stock movers are worth checking out as we dive into all of the biggest ones worth watching on Wednesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 04, 2024
Via
Benzinga
Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting
June 03, 2024
From
Calidi Biotherapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 31, 2024
Via
Benzinga
Dow Surges 250 Points; MongoDB Shares Plummet
↗
May 31, 2024
Via
Benzinga
Topics
Stocks
Why Calidi Biotherapeutics (CLDI) Stock Is Getting Hammered
↗
May 31, 2024
Calidi Biotherapeutics shares are trading lower by 30.7% during Friday's session. The company announced a definitive agreement for the immediate exercise of certain warrants.
Via
Benzinga
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
May 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 31, 2024
Via
Benzinga
Nasdaq Down 1.5%; Gap Shares Spike Higher
↗
May 31, 2024
Via
Benzinga
US Stocks Mostly Higher; Headline PCE Inflation Matches Estimates
↗
May 31, 2024
Via
Benzinga
Topics
Economy
Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
May 31, 2024
From
Calidi Biotherapeutics, Inc.
Via
Business Wire
ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
May 24, 2024
Via
ACCESSWIRE
Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV
May 17, 2024
Via
ACCESSWIRE
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q1 2024
↗
May 14, 2024
CLDI stock results show that Calidi Biotherapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
May 14, 2024
From
Calidi Biotherapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
May 13, 2024
Via
Benzinga
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
May 01, 2024
From
Calidi Biotherapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 23, 2024
Via
Benzinga
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
April 23, 2024
From
Calidi Biotherapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
April 19, 2024
Via
Benzinga
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
April 19, 2024
From
Calidi Biotherapeutics, Inc.
Via
Business Wire
S&P 500 Edges Lower; PacBio Shares Plunge
↗
April 16, 2024
U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling around 0.3% on Tuesday. The Dow traded up 0.02% to 37,741.96 while the NASDAQ fell 0.20% to 15,853.39. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
April 16, 2024
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today